Hyperbaric Radiation Sensitization of Head and Neck Cancers
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
There is reason to believe that hyperbaric oxygen administered immediately prior to
radiotherapy will prove beneficial for this cancer type and stage. The basis for this
hypothesis is a review of several decades of published work, the conclusion of a recent
(2018) Cochrane Review, and results of a Phase I trial.
Phase:
Phase 2
Details
Lead Sponsor:
National Baromedical Services
Collaborators:
59th Medical Wing CISSS de Chaudière-Appalaches Dartmouth-Hitchcock Medical Center David Grant U.S. Air Force Medical Center Hôtel-Dieu de Lévis Mayo Clinic Memorial Hermann Hospital Prisma Health Richland Hospital Wilford Hall Medical Center William Jennings Bryan Dorn VA Medical Center